Transdermal administration of oxybutynin

Details Transdermal administration of oxybutynin Transdermal administration of oxybutynin

A - Human Necessities

61

K

A61K 47/14 (2006.01) A61K 9/70 (2006.01) A61K 31/215 (2006.01) A61K 31/216 (2006.01) A61K 31/22 (2006.01)

Patent

CA 2132865

The present invention is directed to the transdermal administration of oxybutynin together with a suitable permeation en- hancer. The invention includes a transdermal drug delivery device comprising a matrix adapted to be placed in oxybutynin- and permeation enhancer-transmitting relation with the skin site. The matrix contains sufficient amounts of a permeation enhancer and of oxybutynin, in combination, to continuously administer to the skin for a predetermined period of time the oxybutynin to provide an effective therapeutic result. The invention is also directed to a method for the transdermal administration of a thera- peutically effective amount of oxybutynin together with a skin permeation- enhancing amount of a suitable permeation enhancer.

Affiliated with

Also associated with

Rating

Transdermal administration of oxybutynin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transdermal administration of oxybutynin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal administration of oxybutynin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2070350